|
FY2025
12 months to Jan 31, 2026
|
FY2024
12 months to Feb 1, 2025
|
FY2023
12 months to Feb 3, 2024
|
FY2022
12 months to Jan 28, 2023
|
FY2021
12 months to Jan 29, 2022
|
|
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | |||||
| Depreciation | |||||
| Provision for customer credit losses | |||||
| Purchase premium and premium amortization of investments | |||||
| (Gain) Loss on sale of assets held for investment | |||||
| Share based compensation | |||||
| Deferred income taxes | |||||
| (Gain) loss on disposal of property and equipment | |||||
| Impairment of assets | |||||
| Changes in operating assets and liabilities which provided (used) cash: | |||||
| Accounts receivable | |||||
| Merchandise inventories | |||||
| Prepaid and other assets | |||||
| Operating lease right-of-use assets and liabilities | |||||
| Accrued income taxes | |||||
| Accounts payable, accrued expenses and other liabilities | |||||
| Net cash (used in) provided by operating activities | |||||
| Investing Activities: | |||||
| Expenditures for property and equipment | |||||
| Purchase of short-term investments | |||||
| Sales of short-term investments | |||||
| Purchase of other assets | |||||
| Sales of other assets | |||||
| Net cash (used in) provided by investing activities | |||||
| Financing Activities: | |||||
| Dividends paid | |||||
| Repurchase of common stock | |||||
| Proceeds from employee stock purchase plan | |||||
| Net cash used in financing activities | |||||
| Net (decrease) increase in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash at beginning of period | |||||
| Cash, cash equivalents, and restricted cash at end of period | |||||
| Non-cash activity: | |||||
| Accrued property and equipment expenditures | |||||
| Accrued treasury stock | |||||
| Life insurance receivable | |||||
Loading...
